Sign in
CSCI Stock Price, Chart, Stats & News
COSCIENS Biopharma Inc.
Save
8.57M
Market cap
–
Current P/E
–
Forward P/E
CSCI chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 45.58% |
Operating margin | -197.72% |
Pretax margin | -189.25% |
Net margin | -199.53% |
Effective tax rate | -5.44% |
ROA | -68.33% |
ROE | -149.40% |
D/E | 0.32x |
Interest coverage ratio | -136.07x |
CSCI valuation
P/E | – |
P/S | 0.91x |
P/B | 1.22x |
P/CF | -0.51x |
P/FCF | -0.47x |
P/OCF | -0.51x |
PEG | 0.13x |
EV multiple | -0.96x |
About
COSCIENS Biopharma Inc. is a specialized biopharmaceutical company dedicated to the global development and commercialization of innovative therapeutic and diagnostic products. Its operations extend across Canada, Switzerland, Ireland, Denmark, Germany, the United States, and other international territories. The company's flagship product is Macrilen (macimorelin), an orally administered peptidomimetic ghrelin receptor (GHSR-1a) agonist.
Similar securities
Based on sector and market capitalization
Report issue